

The global prevalence of diabetes continues to rise, making it one of the main non-communicable diseases worldwide. For decades, global surveillance has focused on incidence, prevalence, and mortality, reflecting traditional priorities in diabetes management such as diagnosis and glycaemic control. However, this relatively narrow focus does not fully reflect the complexity of the disease. Type 2 diabetes is increasingly diagnosed in younger populations, and type 1 diabetes is also increasingly recognised in older age groups.
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet